Wellgistics said it secured contractual rights to preferred pricing for medical insurance eligibility and benefits verification (EBV) services, which it is making available immediately through its EinsteinRx platform. The company said it expects EBV to become a meaningful component of its revenue stream beginning in Q2 2026. Wellgistics cited an estimate that the EBV market will grow to USD 3 billion in 2030 from USD 2.39 billion in 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief on March 11, 2026, and is solely responsible for the information contained therein.
Comments